Microbix talks on licence for breakthrough flu vaccine process extended

TORONTO (CP) - A Canadian biotech firm that is looking to licence a process that could revolutionize flu vaccine production is expected to announce it is extending talks with an unnamed global vaccine manufacturer. Microbix Biosystems Inc....More